{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:09:29Z","timestamp":1788055769719,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grants-in-Aid"},{"name":"Research Center for Advanced Molecular Medicine, Fukuoka University"},{"DOI":"10.13039\/501100005738","name":"Central Research Institute of Fukuoka University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.lungcan.2018.09.019","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T01:29:49Z","timestamp":1538011789000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8872-8957","authenticated-orcid":false,"given":"Yoshiaki","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Makihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2018.09.019_bib0005","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0010","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/14656566.2016.1176145","article-title":"Advances in treatment of mesothelioma","volume":"17","author":"Maggioni","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0015","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thx.52.6.507","article-title":"Malignant mesothelioma in south east England: clinicopathological experience of 272 cases","volume":"52","author":"Yates","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","article-title":"Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales","volume":"88","author":"Beckett","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lungcan.2015.05.014","article-title":"Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England","volume":"89","author":"Damhuis","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0045","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis","volume":"139","author":"Wu","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0060","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0065","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"24","author":"Churg","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European respiratory society and the european society of thoracic surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0075","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/PAS.0000000000000616","article-title":"BAP1 immunohistochemistry and p16 FISH in the diagnosis of sarcomatous and desmoplastic mesotheliomas","volume":"40","author":"Hwang","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/110.2.191","article-title":"The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: A histologic and immunohistochemical analysis of 31 cases including p53 immunostaining","volume":"110","author":"Mangano","year":"1998","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.lungcan.2009.01.011","article-title":"Accuracy of pathological diagnosis of mesothelioma cases in Japan: Clinicopathological analysis of 382 cases","volume":"66","author":"Takeshima","year":"2009","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.10923","article-title":"The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions","volume":"99","author":"Illei","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0095","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/modpathol.2009.186","article-title":"CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival","volume":"23","author":"Krasinskas","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0105","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jcp.2010.076794","article-title":"FISH assay development for the detection of p16\/CDKN2A deletion in malignant pleural mesothelioma","volume":"63","author":"Chung","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1440-1827.2010.02534.x","article-title":"9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis","volume":"60","author":"Takeda","year":"2010","journal-title":"Pathol. Int."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1309\/AJCPP5R2ZJZKCLWN","article-title":"The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations","volume":"135","author":"Monaco","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cncy.21269","article-title":"Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology","volume":"121","author":"Matsumoto","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/PAS.0000000000000176","article-title":"p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma","volume":"38","author":"Hwang","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0130","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2016.07.011","article-title":"Low homozygous\/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma","volume":"99","author":"Hamasaki","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cncy.21928","article-title":"A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma","volume":"126","author":"Kinoshita","year":"2018","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/dc.23491","article-title":"BAP1 immunostain and CDKN2A (p16) FISH analysis: clinical applicability for the diagnosis of malignant mesothelioma in effusions","volume":"44","author":"Walts","year":"2016","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0155","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/pin.12453","article-title":"BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests","volume":"66","author":"Hida","year":"2016","journal-title":"Pathol. Int."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0160","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0165","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0170","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","article-title":"Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology","volume":"28","author":"Andrici","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0175","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0180","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/his.13321","article-title":"Diagnostic application of BAP1 immunohistochemistry to differentiate pleural mesothelioma from metastatic pleural tumours","volume":"71","author":"Yoshimura","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0185","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0190","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/his.13123","article-title":"Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma","volume":"70","author":"Shinozaki-Ushiku","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0195","doi-asserted-by":"crossref","first-page":"59314","DOI":"10.18632\/oncotarget.10653","article-title":"Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma","volume":"7","author":"Carbone","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0200","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","article-title":"Improving the accuracy of mesothelioma diagnosis in China","volume":"12","author":"Guo","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0205","doi-asserted-by":"crossref","first-page":"68863","DOI":"10.18632\/oncotarget.20317","article-title":"Diagnostic accuracy of BRCA1-associated protein 1 in malignant mesothelioma: a meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0210","series-title":"WHO Classification of Tumours of the Lung, Plura, Thymus and Heart 2015","author":"Travis","year":"2015"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0215","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/cas.12769","article-title":"Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue","volume":"106","author":"Hida","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"World Health Organization Committee for Tumors of the Pleura, The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/modpathol.2009.180","article-title":"Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases","volume":"23","author":"Klebe","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0230","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/dc.23501","article-title":"Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations","volume":"44","author":"Nabeshima","year":"2016","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0235","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5858\/arpa.2012-0108-OA","article-title":"P16 deletion in sarcomatoid tumors of the lung and pleura","volume":"137","author":"Tochigi","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0240","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas","volume":"9","author":"Illei","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-4608(01)00444-7","article-title":"Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types","volume":"129","author":"Gursky","year":"2001","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0250","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1073\/pnas.93.12.6203","article-title":"Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers","volume":"93","author":"Nobori","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10637-008-9160-1","article-title":"A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer","volume":"27","author":"Kindler","year":"2009","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.lungcan.2018.09.019_bib0260","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","article-title":"New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment","volume":"18","author":"Ladanyi","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0265","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PAT.0000000000000250","article-title":"Loss of expression of BAP1 predicts longer survival in mesothelioma","volume":"47","author":"Farzin","year":"2015","journal-title":"Pathology."},{"key":"10.1016\/j.lungcan.2018.09.019_bib0270","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/modpathol.2009.117","article-title":"Delay to formalin fixation effect on breast biomarkers","volume":"22","author":"Khoury","year":"2009","journal-title":"Mod. Pathol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218305786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218305786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T04:46:40Z","timestamp":1605070000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218305786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":54,"alternative-id":["S0169500218305786"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.09.019","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}